Gene Nudelman: Can a Hemostatic Gauze Perform When Blood Clotting is Impaired?
Gene Nudelman, CEO at Core Scientific Creations Ltd, shared a post on LinkedIn:
“Can a hemostatic gauze perform when blood clotting is impaired?
Independent testing conducted at the University Hospital of Tübingen evaluated Wound Clot Advanced Bleeding Control in fresh human blood containing increasing concentrations of heparin.
The results demonstrated clot formation an000d coagulation activation in blood containing up to 3–4 IU/mL heparin, highlighting Wound Clot’s ability to support hemostasis under challenging anticoagulated conditions.
For trauma teams, surgeons, military medics, and emergency responders, every second matters – and so does confidence in the technology being used.
When clotting is compromised, performance matters.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI